(Press-News.org) New Rochelle, NY, March 1, 2013—Most adults and children with type 1 diabetes are not in optimal glycemic control, despite advances in insulin formulations and delivery systems and glucose monitoring approaches. Critical barriers to optimal glycemic control remain. A panel of experts in diabetes management and research met to explore these challenges, and their conclusions and recommendations for how to improve care and optimize clinical decision-making are presented in a white paper in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The paper is available free on the Diabetes Technology & Therapeutics website at http://www.liebertpub.com/dia.
Lead author Richard Bergenstal, MD, International Diabetes Center at Park Nicollet (IDC), outlines the critical issues impacting diabetes management as identified by the panel of luminaries in the field of diabetes during meetings facilitated by the IDC and funded by the Helmsley Charitable Trust. The team of authors emphasizes the critical need for standardization in the collection, reporting, visualization, and analysis of glucose monitoring data, and proposes clear and practical recommendations for implementing these solutions.
The expert panel included DTT Editor-in-Chief Satish Garg, MD, DTT Senior Editor Irl Hirsch, MD, and Andrew Ahmann, MD, Timothy Bailey, MD, Roy Beck, MD, PhD, Joan Bissen, Bruce Buckingham, MD, Larry Deeb, MD, Robert Dolin, MD, Robin Goland, MD, David Klonoff, MD, Davida Kruger, MSN, Glenn Matfin, MB ChB, MSc, Roger Mazze, PhD, Beth Olson, BAN, RN, Christopher Parkin, MS, Anne Peters, MD, Margaret Powers, PhD, Henry Rodriguez, MD, Phil Southerland, Ellie Strock, ANP-BC, William Tamborlane, MD, and David Wesley.
"Glucose monitoring is an essential part of effective diabetes management, and although it has come a long way, both health care providers and patients are frustrated that glucose data reporting has not been standardized," says Satish Garg, MD, Editor-in-Chief of the Journal and Professor of Medicine and Pediatrics at the University of Colorado Denver. "The recommendations reported in this white paper are a good first step toward improving health care outcomes in type 1 diabetes."
The white paper is accompanied by three Commentaries: one by DTT Editor-in-Chief Satish Garg, MD, one by Francine Ratner Kaufman, MD, Medtronic and Children's Hospital, Los Angeles, and one by Aaron Kowalski, PhD and Sanjoy Dutta, PhD, Juvenile Diabetes Research Foundation.
INFORMATION:
About the Journal
Diabetes Technology & Therapeutics is a monthly peer-reviewed journal that covers new technology and new products for the treatment, monitoring, diagnosis, and prevention of diabetes and its complications. Led by Editor-in-Chief Satish Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado Denver, the Journal covers topics that include noninvasive glucose monitoring, implantable continuous glucose sensors, novel routes of insulin administration, genetic engineering, the artificial pancreas, measures of long-term control, computer applications for case management, telemedicine, the Internet, and new medications. Tables of content and a sample issue may be viewed on the Diabetes Technology & Therapeutics website at http://www.liebertpub.com/dia.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Journal of Aerosol Medicine and Pulmonary Drug Delivery, Metabolic Syndrome and Related Disorders, Childhood Obesity, and Population Health Management. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website at http://www.liebertpub.com.
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 www.liebertpub.com
Phone: 914-740-2100 800-M-LIEBERT Fax: 914-740-2101
New guidelines for standardizing glucose reporting and optimizing clinical decision making in diabetes
2013-03-01
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Mechanisms regulating inflammation associated with type 2 diabetes, cancer identified
2013-03-01
(Boston) – A study led by researchers at Boston University School of Medicine (BUSM) has identified epigenetic mechanisms that connect a variety of diseases associated with inflammation. Utilizing molecular analyses of gene expression in macrophages, which are cells largely responsible for inflammation, researchers have shown that inhibiting a defined group of proteins could help decrease the inflammatory response associated with diseases such as obesity, type 2 diabetes, cancer and sepsis.
The study, which is published online in the Journal of Immunology, was led by ...
'Where you're treated matters' in terms of cancer survival
2013-03-01
SEATTLE – A study of older patients with advanced head and neck cancers has found that where they were treated significantly influenced their survival.
The study, led by researchers at Fred Hutchinson Cancer Research Center and published in the March 1 online edition of Cancer, found that patients who were treated at hospitals that saw a high number of head and neck cancers were 15 percent less likely to die of their disease as compared to patients who were treated at hospitals that saw a relatively low number of such cancers. The study also found that such patients ...
Illinois town provides a historical foundation for today's bee research
2013-03-01
CHAMPAIGN, Ill. — A study published in the journal Science reveals a decline in bee species since the late 1800s in West Central Illinois. The study could not have been conducted without the work of a 19th-century naturalist, says a co-author of the new research.
Charles Robertson, a self-taught entomologist who studied zoology and botany at Harvard University and the University of Illinois, was one of the first scientists to make detailed records of the interactions of wild bees and the plants they pollinate, says John Marlin, a co-author of the new analysis in Science. ...
New chemical probe provides tool to investigate role of malignant brain tumor domains
2013-03-01
CHAPEL HILL, N.C. – In an article published as the cover story of the March 2013 issue of Nature Chemical Biology, Lindsey James, PhD, research assistant professor in the lab of Stephen Frye, Fred Eshelman Distinguished Professor in the UNC School of Pharmacy and member of the UNC Lineberger Comprehensive Cancer Center, announced the discovery of a chemical probe that can be used to investigate the L3MBTL3 methyl-lysine reader domain. The probe, named UNC1215, will provide researchers with a powerful tool to investigate the function of malignant brain tumor (MBT) domain ...
Study confirms safety of colonoscopy
2013-03-01
Colon cancer develops slowly. Precancerous lesions usually need many years to turn into a dangerous carcinoma. They are well detectable in an endoscopic examination of the colon called colonoscopy and can be removed during the same examination. Therefore, regular screening can prevent colon cancer much better than other types of cancer. Since 2002, colonoscopy is part of the national statutory cancer screening program in Germany for all insured persons aged 55 or older.
However, only one fifth of those eligible actually make use of the screening program. The reasons ...
Towards more sustainable construction
2013-03-01
This press release is available in French.
Montreal, March 1, 2013 – Construction in Montreal is under a microscope. Now more than ever, municipal builders need to comply with long-term urban planning goals. The difficulties surrounding massive projects like the Turcot interchange lead Montrealers to wonder if construction in this city is headed in the right direction. New research from Concordia University gives us hope that this could soon be the case if sufficient effort is made.
A team of graduate students from Concordia's Department of Geography, Planning and Environment ...
How do bacteria clog medical devices? Very quickly.
2013-03-01
A new study has examined how bacteria clog medical devices, and the result isn't pretty. The microbes join to create slimy ribbons that tangle and trap other passing bacteria, creating a full blockage in a startlingly short period of time.
The finding could help shape strategies for preventing clogging of devices such as stents — which are implanted in the body to keep open blood vessels and passages — as well as water filters and other items that are susceptible to contamination. The research was published in Proceedings of the National ...
New study could explain why some people get zits and others don't
2013-03-01
The bacteria that cause acne live on everyone's skin, yet one in five people is lucky enough to develop only an occasional pimple over a lifetime.
In a boon for teenagers everywhere, a UCLA study conducted with researchers at Washington University in St. Louis and the Los Angeles Biomedical Research Institute has discovered that acne bacteria contain "bad" strains associated with pimples and "good" strains that may protect the skin.
The findings, published in the Feb. 28 edition of the Journal of Investigative Dermatology, could lead to a myriad of new therapies to ...
Where the wild things go… when there's nowhere else
2013-03-01
Ecologists have evidence that some endangered primates and large cats faced with relentless human encroachment will seek sanctuary in the sultry thickets of mangrove and peat swamp forests. These harsh coastal biomes are characterized by thick vegetation — particularly clusters of salt-loving mangrove trees — and poor soil in the form of highly acidic peat, which is the waterlogged remains of partially decomposed leaves and wood. As such, swamp forests are among the few areas in many African and Asian countries that humans are relatively less interested in exploiting (though ...
Thyroid hormones reduce damage and improve heart function after myocardial infarction in rats
2013-03-01
Thyroid hormone treatment administered to rats at the time of a heart attack (myocardial infarction) led to significant reduction in the loss of heart muscle cells and improvement in heart function, according to a study published by a team of researchers led by A. Martin Gerdes and Yue-Feng Chen from New York Institute of Technology College of Osteopathic Medicine.
The findings, published in the Journal of Translational Medicine, have bolstered the researchers' contention that thyroid hormones may help reduce heart damage in humans with cardiac diseases.
"I am extremely ...